Press Releases

Jochen Schlindwein
Jochen Schlindwein becomes new Managing Director
Following the departure of Dr. Marcus Wörwag from the management of Wörwag Pharma GmbH & Co. KG, Mr. Jochen Schlindwein will assume management as Managing Director and CEO, starting on December 1, 2019. He will manage the business operations of the Wörwag group together with Mr. Gerhard Mayer, Managing Director and CFO.
Monika Wörwag
Positive development in Eastern Europe: Wörwag Pharma with rise of sales in first half of 2019
With an increase in sales of 8.7 percent, i. e. 118.2 million Euro, compared to the previous year, the family-owned pharma company Wörwag Pharma has successfully finished the first half of 2019.
Dr. Marcus Wörwag
Wörwag Pharma: Change in Management Board
After 18 years of leading Wörwag Pharma GmbH & Co. KG, Dr. Marcus Wörwag will withdraw from the company’s Management Board as of January 2019. Marcus Wörwag will join the Advisory Board and in this function will further develop the strategic direction of the group. Managing Directors Monika Wörwag and Gerhard Mayer henceforth will lead the company together.
European Diabetes Congress: Experts call for more attention to be paid to the feet of diabetics
Neuropathy is a common and serious secondary disease of diabetes. However, it is often not recognised for a long time. For this reason, experts from six European countries discussed at the Congress of the EASD (European Association for the Study of Diabetes) in Berlin how the early diagnosis of neuropathies can be improved.
Fritz Wörwag Research Prize
Fritz Wörwag Research Prize: New Findings on Neuroprotective Effects of Biofactors
On the occasion of the congress of the German Diabetes Society 2018, the Fritz Wörwag Research Prize was awarded on May 9 for new findings on biofactors – this year on the topic of "Biofactors for Neuroprotection".
Wörwag Pharma Expands Leadership Team - Irmgard Neuper New Director of Operations
In March 2018, Irmgard Neuper started her now role as Director of Operations of family-owned company Wörwag Pharma, headquartered in Böblingen. Her responsibilities include international regulatory affairs, quality assurance and product development.
Positive development in Russia and Eastern Europe: Wörwag Pharma increases its sales in 2017
With an increase in sales of 28 million Euros (16.2%) as compared to the previous year to 201.3 million Euros, Wörwag Pharma, the family-owned company from Böblingen, brought 2017 to a successful end.
Wörwag Pharma Strengthens International Distribution: Marc Westermann New Director of Global Sales
On March 1, 2018, Marc Westermann (49) began working for Böblingen-based pharmaceutical company Wörwag Pharma as Director of Global Sales. He is a graduate economist with more than twenty years of experience in the pharmaceutical industry, both in large company groups and medium-sized enterprises.

Press Contact

Kerstin Imbery-Will
Kerstin Imbery-WillPublic relations+49 4183 774623kerstin.imbery-will@woerwagpharma.com
Dr. Beate Rzadtki
Dr. Beate RzadtkiCompany communication+49 7031 6204 – 338beate.rzadtki@woerwagpharma.com